ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,970.84
-1.11%
Dow Jones
42,992.21
-0.77%
US Dollar vs MXN
20.3272
0.00%
Brent Oil
73.44
0.00%
Bitcoin
94,852.95
0.73%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. OSE Immunotherapeutics (OSE) Cotización

OSE Immunotherapeutics

OSE Immunotherapeutics (OSE)

EU
7.27
0.21
(2.97%)
Cerrado 28 Diciembre 10:30AM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
7.27
Postura de Compra
7.25
Postura de Venta
7.39
Volume Operado de la Acción
193,635
7.16 Rango del Día 7.52
3.115 Rango de 52 semanas 11.58
Capitalización de Mercado [m]
158.252M
Precio Anterior
7.06
Precio de Apertura
7.18
Hora
1
@
7.27
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
193,487
Acciones en circulación
21,767,777
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-6.88
Beneficio por acción (BPA)
-1.06
turnover
2.23M
Beneficio neto
-23M

Acerca de OSE Immunotherapeutics

Sector
Coml Physical, Biologcl Resh
Industria
Coml Physical, Biologcl Resh
Sitio web
www.ose-immuno.com
Sede
Nantes, Loire-atlantique, Fra
Fundado
-
OSE Immunotherapeutics is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker OSE. The last closing price for OSE Immunotherapeutics was 7.06 €. Over the last year, OSE Immunotherapeutics shares have traded in a share price range of 3.115 € to 11.58 €.

OSE Immunotherapeutics currently has 21,767,777 shares in issue. The market capitalisation of OSE Immunotherapeutics is 153.68 € million. OSE Immunotherapeutics has a price to earnings ratio (PE ratio) of -6.88.

OSE Últimas noticias

Más noticias

OSE Immunotherapeutics présentera les résultats d’induction de Phase 2 de l’anti-IL-7R Lusvertikimab dans la rectocolite hémorragique au 20ème congrès de l’ECCO

OSE Immunotherapeutics présentera les résultats d’induction de Phase 2 de l’anti-IL-7R Lusvertikimab dans la rectocolite hémorragique au 20ème congrès de l’ECCO Un abstract clinique sur les...

18 Diciembre 2024
UK Regulatory

OSE Immunotherapeutics to Present Anti-IL-7R Lusvertikimab Phase 2 Induction Results in Ulcerative Colitis at 20th Congress of ECCO

OSE Immunotherapeutics to Present Anti-IL-7R Lusvertikimab Phase 2 Induction Results in Ulcerative Colitis at 20th Congress of ECCO A clinical abstract on the induction results from the CoTikiS...

18 Diciembre 2024
UK Regulatory

OSE Immunotherapeutics annonce des avancées cliniques positives de Tedopi®, son vaccin thérapeutique contre le cancer en développement avancé

OSE Immunotherapeutics annonce des avancées cliniques positives de Tedopi®, son vaccin thérapeutique contre le cancer en développement avancé OSE Immunotherapeutics annonce des avancées cliniques...

11 Diciembre 2024
UK Regulatory

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi®

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi® ARTEMIA: Clinical trial protocol approved globally. Most countries and sites...

11 Diciembre 2024
GlobeNewswire Inc.

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi®

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi® OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary...

11 Diciembre 2024
UK Regulatory

OSE Immunotherapeutics : Informations Relatives au Nombre Total de Droits de Vote et d’Actions Composant le Capital

OSE Immunotherapeutics : Informations Relatives au Nombre Total de Droits de Vote et d’Actions Composant le Capital Informations Relatives au Nombre Total de Droits de Vote et d’Actions Composant...

04 Diciembre 2024
UK Regulatory

OSE Immunotherapeutics Strengthens Leadership and Executive Committee

OSE Immunotherapeutics Strengthens Leadership and Executive Committee NANTES, France, December 2, 2024 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced...

02 Diciembre 2024
GlobeNewswire Inc.

OSE Immunotherapeutics Strengthens Leadership and Executive Committee

OSE Immunotherapeutics Strengthens Leadership and Executive Committee OSE Immunotherapeutics Strengthens Leadership and Executive Committee NANTES, France, December 2, 2024 – 6:00pm CET - OSE...

02 Diciembre 2024
UK Regulatory

OSE Immunotherapeutics Renforce son Équipe de Direction et son Comité Exécutif

OSE Immunotherapeutics Renforce son Équipe de Direction et son Comité Exécutif OSE Immunotherapeutics Renforce son Équipe de Direction et son Comité Exécutif Nantes, France, le 2 décembre 2024...

02 Diciembre 2024
UK Regulatory

Informations relatives au nombre total de droits de vote et d’actions composant le capital

Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 4 novembre 2024 – En application de l’article L. 233-8 II du Code de commerce et de l’article...

04 Noviembre 2024
UK Regulatory
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.121.678321678327.157.526.81049817.04754644DE
4-1.68-18.77094972078.9596.81449077.48640915DE
12-1.67-18.68008948558.9411.586.81934879.1595356DE
261.1719.18032786896.111.585.371864948.20526949DE
523.1777.31707317074.111.583.1151709727.1509087DE
156-3.13-30.096153846210.411.582.7051072716.34323124DE
2603.6399.72527472533.6415.82.7051015657.4227915DE

OSE - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de OSE Immunotherapeutics?
El precio actual de las acciones de OSE Immunotherapeutics es 7.27 €
¿Cuántas acciones de OSE Immunotherapeutics están en circulación?
OSE Immunotherapeutics tiene 21,767,777 acciones en circulación
¿Cuál es la capitalización de mercado de OSE Immunotherapeutics?
La capitalización de mercado de OSE Immunotherapeutics es EUR 153.68M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de OSE Immunotherapeutics?
OSE Immunotherapeutics ha negociado en un rango de 3.115 € a 11.58 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de OSE Immunotherapeutics?
El ratio precio/beneficio de OSE Immunotherapeutics es -6.88
¿Cuál es el ratio de efectivo a ventas de OSE Immunotherapeutics?
El ratio de efectivo a ventas de OSE Immunotherapeutics es 71.07
¿Cuál es la moneda de reporte de OSE Immunotherapeutics?
OSE Immunotherapeutics presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de OSE Immunotherapeutics?
El último ingresos anual de OSE Immunotherapeutics es EUR 2.23M
¿Cuál es el último beneficio anual de OSE Immunotherapeutics?
El último beneficio anual de OSE Immunotherapeutics es EUR -23M
¿Cuál es la dirección registrada de OSE Immunotherapeutics?
La dirección registrada de OSE Immunotherapeutics es 22 BOULEVARD DE BENONI GOULLIN, NANTES, LOIRE-ATLANTIQUE, 44200
¿Cuál es la dirección del sitio web de OSE Immunotherapeutics?
La dirección del sitio web de OSE Immunotherapeutics es www.ose-immuno.com
¿En qué sector industrial opera OSE Immunotherapeutics?
OSE Immunotherapeutics opera en el sector COML PHYSICAL, BIOLOGCL RESH

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALEMSEuropean Medical Solutions
6.70 €
(37,122.22%)
40
CFNCofina SGPS SA
15.95 €
(2,146.48%)
2.17k
DMSBSDiagnostic Medical Systems
0.003 €
(50.00%)
52k
ALTROTronic s Microsystems
5.00 €
(48.81%)
8
SEQUASequana medical NV
3.87 €
(40.22%)
2.43M
EIFDSTour Eiffel DS
0.0184 €
(-57.41%)
110.23k
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
ALMEXMexedia SPA
5.00 €
(-23.08%)
40
ALEUPEuroplasma
0.0413 €
(-14.67%)
3.93M
MLFMVFarminveste
1.20 €
(-14.29%)
1.36k
ATOAtos SE
0.0027 €
(17.39%)
3.02B
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
NEOENNeoen SA
39.83 €
(0.73%)
81.42M
BCPBanco Comercial Portugues SA
0.4602 €
(2.04%)
75.06M
ALHPIHopium SA
0.005 €
(0.00%)
19.56M

Discusión

Ver feed completo
dstock07734 dstock07734 5 minutos hace
It is a small hedge fund, is it not? IMO, it doesn't have too much investment in biotech. What made the fund have interest in an OTC company?

https://fintel.io/i/ya-global-master-spv
NWBO
al44 al44 5 minutos hace
A real bummer-

https://media.gettr.com/group7/getter/2024/12/28/08/1e68c807-363f-a455-509a-6f30032a4619/14c9728a11e7063fa43c5d799f8664f7_768x0.png
cjstocksup cjstocksup 5 minutos hace
Exactly!
If they're not public then why do the taxpayers have to support them?
luvwetscent luvwetscent 6 minutos hace
One particular basher with a big rack
ELTP
KILLAZILLA KILLAZILLA 6 minutos hace
BEST TO "IGNORE" ALL THE SILLY PUMPERS...they've BEEN WRONG FOR OVER 4 YEARS

THIS POS SCAM IS DOWN OVER 90% WITH ENDLESS PUMP GARBAGE!!!
WDLF
exwannabe exwannabe 7 minutos hace
I agree. Even a $100M upfront payment will lend a ton of credibility. It does not have to be half a billion or billion dollar in upfront payment.

Having said that, LP has already signaled not to expect upfront payment. In fact, my prediction is big pharma won’t even PR combo partnersh
API
cjstocksup cjstocksup 7 minutos hace
Thanks for posting that. Like I said I know at least 30 people close to me who did this and made America better. Some came here as far back as the 1970's just to go to college and became citizens instead of going back to where they came from etc.
Trump has told NYP that he supports immigrati
ddls ddls 7 minutos hace
It's not about posts on message boards, it's about profits the company makes and GROWTH.🤠
BIEL
Konaploinks Konaploinks 7 minutos hace
Target 126.00
IONQ
al44 al44 8 minutos hace
It happened at a New York Airport. This is hilarious. I wish I had the guts of this girl. An award should go to the United
Airlines gate agent in New York for being smart and funny, while making her point, when confronted with a passenger who probably
deserved to fly as cargo. For all
tdbowieknife tdbowieknife 8 minutos hace
You left out all the fraud committed by GRLT concerning the Pretzel Haus.

.

Buyer Beware
Pump and Dump
http://images.investorshub.advfn.com/images/uploads/2013/12/13/fowqcCaveat_Emptor_5.JPG


..
GRLT
SuperLogisticsMan SuperLogisticsMan 9 minutos hace
Partly why I added to my position this past week. Go $CYBL!
CYBL
SuperLogisticsMan SuperLogisticsMan 9 minutos hace
UAS-Pro...love your posts. Hope and pray that your prognostication comes true!

HNY to you and mauiguy2! And prayers to Gosox! $CYBL
CYBL
Juststoppingby Juststoppingby 10 minutos hace
They added 21,500 shares to the 150,000 shares of Series D Preferred Stock, which is just over 143 million cheers on a fully diluted basis. They expect to never convert those shares to Coretec’s public shares.
“Additionally, holders of Series D Preferred Shares may elect to exchange their sha
CRTG
PickStocks PickStocks 10 minutos hace
Nothing to do with old escrows......only JPM....
JPM
BullNBear52 BullNBear52 11 minutos hace
Pity the lab rats stuck in NC. Though I must admit NC has the best of both worlds with the mountains and the beaches.
PickStocks PickStocks 12 minutos hace
Not dependent on a new administration.....he is just leading you on.....
COOP
misterfishman misterfishman 12 minutos hace
Be nice a new year is coming.
IGPK
frrol frrol 12 minutos hace
Yes.
AVXL
glenn1919 glenn1919 13 minutos hace
inuv.......................https://stockcharts.com/h-sc/ui?s=inuv&p=D&yr=0&mn=2&dy=12&id=p84071410134
TenKay TenKay 13 minutos hace
Hostile takeover? There was zero risk of that as Foote had voting control. Nobody could takeover if he didn’t want them to.

What is happening…and let’s use the patent as an example since you are referring to it…is this:

Let’s say it has significant value…say $100 mill
HMBL
cjstocksup cjstocksup 13 minutos hace
@elonmusk
·
22h
Anyone – of any race, creed or nationality – who came to America and worked like hell to contribute to this country will forever have my respect.

America is the land of freedom and opportunity. Fight with every fiber of your being to keep it that w
Investor082 Investor082 15 minutos hace
I agree. Even a $100M upfront payment will lend a ton of credibility. It does not have to be half a billion or billion dollar in upfront payment.

Having said that, LP has already signaled not to expect upfront payment. In fact, my prediction is big pharma won’t even PR combo partners
NWBO
Raysfan1 Raysfan1 15 minutos hace
I read on Stock Twits that it is for 90 minutes and there are only 3 firms that have that amount of time.
AVXL
Raysfan1 Raysfan1 15 minutos hace
I read on Stock Twits that it is for 90 minutes and there are only 3 firms that have that amount of time.
AVXL

Su Consulta Reciente

EU
OSE
OSE Immunotherapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados